OcuTerra Therapeutics
Dr. Lindstrom is a Founder and Attending Surgeon at Minnesota Eye Consultants, P.A., a provider of eye care services. A Board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive, and laser surgery, Dr. Lindstrom has developed a number of solutions, intraocular lenses, and instruments that are used in clinical practices globally. He is an Adjunct Clinical Professor Emeritus at the University of Minnesota, Department of Ophthalmology. He is a Board Member: of the University of Minnesota Foundation, Visiting Professor, at UC Irvine‘s Gavin Herbert Eye Institute. He also is the past President of the American Society of Cataract and Refractive Surgeons and the International Society of Refractive Surgery. Dr. Lindstrom holds a B.A. in pre-medical studies, a B.S. in Medicine, and an M.D. from the University of Minnesota.
This person is not in the org chart
This person is not in any offices
OcuTerra Therapeutics
OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity